FDA
Entity.
- Evidence
- 3,442 documents · 277 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 6 Apr 2026, last seen 11 Nov 2026
- Measured
- 36% of mentions say something specific about it; the rest only name it
- As of
- 16 Nov 2026
Where this comes from
- Tech Times · 2026-11-11 · PepGen's Myotonic Dystrophy Drug Sets Phase 2 Efficacy Record: FDA Hold Still Bars American Patients (opens the source in a new tab)
- FDA Drug News · 2026-11-10 · [APPROVAL] FDA approves pembrolizumab with chemoradiotherapy for FIGO 2014 Stage III-IVA cervical cancer (opens the source in a new tab)
- FDA Drug News · 2026-11-10 · [APPROVAL] FDA approves pembrolizumab as adjuvant treatment for non-small cell lung cancer (opens the source in a new tab)
- FDA Drug News · 2026-11-10 · [APPROVAL] FDA approves osimertinib with chemotherapy for EGFR-mutated non-small cell lung cancer (opens the source in a new tab)
- FDA Drug News · 2026-11-10 · [APPROVAL] FDA approves osimertinib for locally advanced, unresectable (stage III) non-small cell lung cancer following chemoradiation therapy (opens the source in a new tab)
- FDA Drug News · 2026-11-10 · [APPROVAL] FDA approves obecabtagene autoleucel for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (opens the source in a new tab)
- FDA Drug News · 2026-11-10 · [APPROVAL] FDA approves nogapendekin alfa inbakicept-pmln for BCG-unresponsive non-muscle invasive bladder cancer (opens the source in a new tab)
- FDA Drug News · 2026-11-10 · [APPROVAL] FDA approves nivolumab in combination with cisplatin and gemcitabine for unresectable or metastatic urothelial carcinoma (opens the source in a new tab)
- FDA Drug News · 2026-11-10 · [APPROVAL] FDA approves nivolumab for adjuvant treatment of Stage IIB/C melanoma (opens the source in a new tab)
- FDA Drug News · 2026-11-10 · [APPROVAL] FDA approves nivolumab and hyaluronidase-nvhy for subcutaneous injection (opens the source in a new tab)
- FDA Drug News · 2026-11-10 · [APPROVAL] FDA approves new and updated indications for temozolomide under Project Renewal (opens the source in a new tab)
- Food Ingredients First · 2026-11-10 · US FDA revokes authorizations for solvent uses in natural food color manufacturing (opens the source in a new tab)
What is claimed about it
- Reported by two: Reported by two sources that did not copy each other.
- Single source: Reported by one source so far.
- Could not check: We could not count this claim's sources, so we do not say how well it is supported.
- Senate health chair unsure if Trump’s FDA pick has support to pass committee’s vote Could not check · first reported 15 Nov 2026
- PearlBone gets FDA clearance for world's largest orthopaedic market Single source · first reported 14 Nov 2026
- FDA approves durvalumab with enfortumab vedotin-ejfv for muscle invasive bladder cancer Single source · first reported 13 Nov 2026
- Bracco and Avicenna.AI Announce FDA Clearance for UPTUNITY™ | Aneurysm, a New AI-Enabled Software for Brain Aneurysm Detection and Assessment Could not check · first reported 13 Nov 2026
- Lung Cancer Drug Ivonescimab Uses Tumor's Own Growth Signal to Boost Immunity: FDA Votes Saturday Reported by two · first reported 12 Nov 2026
- A Run of FDA Target Dates Fills the Biotech Calendar From Late November to Year End Could not check · first reported 12 Nov 2026
- Merck KGaA wins FDA approval for Pimjetmi in symptomatic tenosynovial giant cell tumor Single source · first reported 11 Nov 2026
- Rare Eye Condition Prompts New FDA Warning On Popular GLP-1 Drugs Single source · first reported 10 Nov 2026
- Virtuoso Surgical’s bladder cancer resection robot secures FDA de novo authorisation Single source · first reported 10 Nov 2026
- FDA authorizes emergency screwworm treatment as Arizona sees cases Could not check · first reported 10 Nov 2026
- FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in MSI-High Solid Tumors Single source · first reported 10 Nov 2026
- Novocure’s device for treating brain metastases rejected by FDA Single source · first reported 10 Nov 2026